Stanford Research

PsyPost: A dream-like psychedelic might help traumatized veterans reset their brains

Covers the Journal of Affective Disorders paper showing that stronger mystical experiences during magnesium–ibogaine were associated with larger symptom reductions. It frames the subjective experience as a possible contributor to therapeutic benefit.

Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

Healthline: Psychedelic Ibogaine May Help PTSD and Depression After Traumatic Brain Injury

Press Release: Veterans Exploring Treatment Solutions (VETS) Grant Recipients Participate in Groundbreaking Stanford Study on Ibogaine Treatment for PTSD and TBI

Stanford Medicine News Center: Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets

Stanford updated its ibogaine feature to describe the July 24, 2025 Nature Mental Health EEG/MRI analysis. It reports increased theta rhythms linked to executive-function gains and reduced cortical complexity linked to PTSD improvement.